Literature DB >> 10886319

Apraxia of lid opening is alleviated by pallidal stimulation in a patient with Parkinson's disease.

S Goto1, K Kihara, T Hamasaki, S Nishikawa, Y Hirata, Y Ushio.   

Abstract

Apraxia of lid opening (ALO) is a syndrome characterized by a non-paralytic inability to open the eyes at will in the absence of visible contraction of the orbicularis oculi muscle. Here we report that globus pallidus internus deep brain stimulation on the right side markedly alleviates ALO as well as gait freezing in a patient with Parkinson's disease.

Entities:  

Mesh：

Year:  2000        PMID： 10886319     DOI： 10.1046/j.1468-1331.2000.00058.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


  6 in total

1.  Apraxia of Eyelid Opening Improved by Pallidal Stimulation in Progressive Supranuclear Palsy.

Authors:  Tseganesh Orcutt; Jerrold Vitek; Rémi Patriat; Noam Harel; Joseph Matsumoto
Journal:  Mov Disord Clin Pract       Date:  2020-07-16

Review 2.  Animal models of focal dystonia.

Authors:  Craig Evinger
Journal:  NeuroRx       Date:  2005-07

3.  Apraxia of Lid Opening in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease-Frequency, Risk Factors and Response to Treatment.

Authors:  Syam Krishnan; Kuldeep Shetty; Divya Kalikavil Puthanveedu; Krishnakumar Kesavapisharady; Jissa Vinoda Thulaseedharan; Gangadhara Sarma; Asha Kishore
Journal:  Mov Disord Clin Pract       Date:  2021-04-12

4.  Delayed Onset Eye Opening Apraxia due to Progression of Brain Atrophy following Subthalamic Nucleus Deep Brain Stimulation: A Case Report.

Authors:  Takashi Morishita; Masa-Aki Higuchi; Yoshio Tsuboi; Kazuhiro Samura; Tooru Inoue
Journal:  NMC Case Rep J       Date:  2016-11-29

5.  Animal models for investigating benign essential blepharospasm.

Authors:  Craig Evinger
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

Review 6.  Eyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease.

Authors:  Ali G Hamedani; Daniel R Gold
Journal:  Front Neurol       Date:  2017-07-18       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.